http://rdf.ncbi.nlm.nih.gov/pubchem/reference/10637795

Outgoing Links

Predicate Object
contentType Comparative Study|Journal Article|Randomized Controlled Trial|Research Support, Non-U.S. Gov't
issn 1935-2735
issueIdentifier 7
pageRange e491-
publicationName PLoS Neglected Tropical Diseases
startingPage e491
bibliographicCitation Miranda-Verastegui C, Tulliano G, Gyorkos TW, Calderon W, Rahme E, Ward B, Cruz M, Llanos-Cuentas A, Matlashewski G. First-Line Therapy for Human Cutaneous Leishmaniasis in Peru Using the TLR7 Agonist Imiquimod in Combination with Pentavalent Antimony. PLoS Negl Trop Dis. 2009 Jul 28;3(7):e491. doi: 10.1371/journal.pntd.0000491.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b18b5da7be6e4910afa0866a2b289a88
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-7567-5534
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d73533fbab21edcb0afa895aebe37f9f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2ce290dfc9a3e47110dac3a8c8953d1a
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5da4e166c15e3546a072f1840dd19fdf
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9ff337c6b5f1f5ec9b103b630cca2913
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7ac4c4a0d187be2a0b9bd38010b180da
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0a0638ad3c7b73ab6e76784b79f2d80d
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cdfd096005c0b4f7a6cbd434185614dc
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6f67617c4744b6496512ac5f327b75cd
date 2009-07-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://doi.org/10.1371/journal.pntd.0000491
https://pubmed.ncbi.nlm.nih.gov/19636365
https://pubmed.ncbi.nlm.nih.gov/PMC2710502
isPartOf https://portal.issn.org/resource/ISSN/1935-2735
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/33851
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title First-Line Therapy for Human Cutaneous Leishmaniasis in Peru Using the TLR7 Agonist Imiquimod in Combination with Pentavalent Antimony
discusses http://id.nlm.nih.gov/mesh/M0479623
http://id.nlm.nih.gov/mesh/M0001497
http://id.nlm.nih.gov/mesh/M0011157
http://id.nlm.nih.gov/mesh/M0158430
http://id.nlm.nih.gov/mesh/M0001472
http://id.nlm.nih.gov/mesh/M0374461
http://id.nlm.nih.gov/mesh/M0000967
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D051199Q000819
http://id.nlm.nih.gov/mesh/D007155Q000627
http://id.nlm.nih.gov/mesh/D000634Q000627
http://id.nlm.nih.gov/mesh/D016773Q000188
http://id.nlm.nih.gov/mesh/D000965Q000627
http://id.nlm.nih.gov/mesh/D000981Q000627
hasSubjectTerm http://id.nlm.nih.gov/mesh/D010568
http://id.nlm.nih.gov/mesh/D004311
http://id.nlm.nih.gov/mesh/D002675
http://id.nlm.nih.gov/mesh/D000077271
http://id.nlm.nih.gov/mesh/D004359
http://id.nlm.nih.gov/mesh/D000368
http://id.nlm.nih.gov/mesh/D008875
http://id.nlm.nih.gov/mesh/D000293
http://id.nlm.nih.gov/mesh/D055815
http://id.nlm.nih.gov/mesh/D000328
http://id.nlm.nih.gov/mesh/D008297
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D005260
http://id.nlm.nih.gov/mesh/D002648
http://id.nlm.nih.gov/mesh/D016896
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9927
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID73608879
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7660
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8173
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_8148778355b8901959ebf6a1622d11e5
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57469

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127765602
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127719861
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135912430
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129621433
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135802183
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128570062
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128953588
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135874467
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136158368
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127796651

Total number of triples: 71.